Cytokinetics to focus on heart disease drug after ALS trial failure https://ift.tt/KrHot5z

The drug is being developed to treat a heart condition called hypertrophic cardiomyopathies, which causes the thickening of heart muscles and can lead to cardiac arrest. Late-stage data from the drug is expected later this year.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/SUueGRy
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.